Dr. Lal PathLabs
Signals mentioning Dr. Lal PathLabs
- Orange Health plans 80 collection centres this year, adds radiology and wearables
- Orange Health to add 80 collection centres this fiscal year, enter radiology
- Healthians posts first annual profit as FY26 operating revenue rises 35.7% to Rs 357 crore
- Healthians posts FY26 profit as operating revenue rises 35.7% to Rs 357 crore
- Forthcoming book profiles Titan’s crisis-to-growth playbook
- Tenet Diagnostics raises $30m to expand centres, B2B labs and acquisitions
- Tata Capital Healthcare Fund leads $30M investment in Tenet Diagnostics
- Redcliffe Labs acquires Pune’s Megavision Diagnostics for about Rs 40 crore
- Metropolis deepens tier-II and III diagnostics network as smaller towns drive growth
- Dr Lal PathLabs may raise FY27 margin guidance after first-half results
- Dr Lal PathLabs beats in Q1; ICICI lifts target to Rs 1,690 but cuts rating to Hold
- Orange Health Labs hits Rs 180 cr ARR as 30-minute home sampling scales across four metros
- Orange Health Labs hits ₹180 cr ARR betting diagnostics is the next quick-commerce category
- Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis